JP2019505531A5 - - Google Patents

Download PDF

Info

Publication number
JP2019505531A5
JP2019505531A5 JP2018540720A JP2018540720A JP2019505531A5 JP 2019505531 A5 JP2019505531 A5 JP 2019505531A5 JP 2018540720 A JP2018540720 A JP 2018540720A JP 2018540720 A JP2018540720 A JP 2018540720A JP 2019505531 A5 JP2019505531 A5 JP 2019505531A5
Authority
JP
Japan
Prior art keywords
formula
compound
acid
sodium
potassium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018540720A
Other languages
English (en)
Japanese (ja)
Other versions
JP6877449B2 (ja
JP2019505531A (ja
Filing date
Publication date
Priority claimed from CN201610082028.3A external-priority patent/CN107043378A/zh
Application filed filed Critical
Publication of JP2019505531A publication Critical patent/JP2019505531A/ja
Publication of JP2019505531A5 publication Critical patent/JP2019505531A5/ja
Application granted granted Critical
Publication of JP6877449B2 publication Critical patent/JP6877449B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018540720A 2016-02-05 2017-02-04 ピロロ[3,2−d]ピリミジン化合物を調製するための方法、及びそれらの中間体 Active JP6877449B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201610082028.3A CN107043378A (zh) 2016-02-05 2016-02-05 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体
CN201610082028.3 2016-02-05
PCT/CN2017/072893 WO2017133686A1 (zh) 2016-02-05 2017-02-04 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体

Publications (3)

Publication Number Publication Date
JP2019505531A JP2019505531A (ja) 2019-02-28
JP2019505531A5 true JP2019505531A5 (https=) 2020-02-27
JP6877449B2 JP6877449B2 (ja) 2021-05-26

Family

ID=59500148

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018540720A Active JP6877449B2 (ja) 2016-02-05 2017-02-04 ピロロ[3,2−d]ピリミジン化合物を調製するための方法、及びそれらの中間体

Country Status (28)

Country Link
US (2) US10654856B2 (https=)
EP (1) EP3412673B1 (https=)
JP (1) JP6877449B2 (https=)
KR (1) KR102371500B1 (https=)
CN (2) CN107043378A (https=)
AR (1) AR107549A1 (https=)
AU (1) AU2017214134B2 (https=)
BR (1) BR112018015879B1 (https=)
CA (1) CA3013520C (https=)
CL (1) CL2018002094A1 (https=)
DK (1) DK3412673T3 (https=)
EA (1) EA034581B1 (https=)
ES (1) ES2852323T3 (https=)
HR (1) HRP20210103T1 (https=)
HU (1) HUE053455T2 (https=)
IL (1) IL260999B (https=)
LT (1) LT3412673T (https=)
MX (1) MX374298B (https=)
MY (1) MY190551A (https=)
NZ (1) NZ744885A (https=)
PH (1) PH12018501642B1 (https=)
PL (1) PL3412673T3 (https=)
PT (1) PT3412673T (https=)
SG (1) SG11201806685VA (https=)
SI (1) SI3412673T1 (https=)
TW (1) TW201728590A (https=)
UA (1) UA124100C2 (https=)
WO (1) WO2017133686A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107043380A (zh) 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
MA44007A (fr) 2016-02-05 2018-12-19 Denali Therapeutics Inc Inhibiteurs du récepteur interagissant avec protéine kinase 1
JP7287708B2 (ja) 2019-02-08 2023-06-06 プロジェニア インコーポレイテッド Toll-like受容体7または8アゴニストとコレステロールの結合体およびその用途
JP7811014B2 (ja) 2020-03-02 2026-02-04 プロジェニア インコーポレイテッド 病原菌外壁成分基盤の生病原体模倣ナノ粒子及びその製造方法
CN116322751A (zh) 2020-08-04 2023-06-23 蛋白科技先锋 包含能够动力学控制的佐剂的mRNA疫苗
JP2023536954A (ja) 2020-08-04 2023-08-30 プロジェニア インコーポレイテッド 活性化部位が一時的に不活性化したトール様受容体7または8作用薬と機能性薬物の結合体およびその用途
US20230355750A1 (en) 2020-08-04 2023-11-09 Progeneer Inc. Kinetically acting adjuvant ensemble
IL314082A (en) 2022-01-12 2024-09-01 Denali Therapeutics Inc Crystal forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido[3,2-b][1,4]oxazapin-3-yl)- H4- 1,2,4-triazole-3-carboxamide

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009082247A1 (en) * 2007-12-21 2009-07-02 Industrial Research Limited Process for preparing immucillins having a methylene link
ES2467108T3 (es) 2008-12-09 2014-06-11 Gilead Sciences, Inc. Moduladores de receptores tipo toll
LT2906563T (lt) * 2012-10-10 2018-06-11 Janssen Sciences Ireland Uc Pirolo[3,2-d]pirimidino dariniai virusinių infekcijų ir kitų ligų gydymui
MX358025B (es) * 2012-11-20 2018-08-02 Glaxosmithkline Llc Star Compuestos novedosos.
US9550785B2 (en) * 2012-11-20 2017-01-24 Glaxosmithkline Llc Pyrrolopyrimidines as therapeutic agents for the treatment of diseases
JP6484253B2 (ja) * 2014-05-01 2019-03-13 ノバルティス アーゲー Toll様受容体7アゴニストとしての化合物および組成物
CN105367576A (zh) 2014-08-15 2016-03-02 正大天晴药业集团股份有限公司 作为tlr7激动剂的吡咯并嘧啶化合物
HUE054672T2 (hu) 2014-08-15 2021-09-28 Chia Tai Tianqing Pharmaceutical Group Co Ltd TLR7 agonistaként alkalmazott pirrolopirimidin vegyületek
CA3004173C (en) 2015-11-05 2020-07-14 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 7-(thiazol-5-yl)pyrrolopyrimidine compound as tlr7 agonist
CN107043379A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的晶型a、其制备方法和医药用途
CN107043380A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
CN107043377A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的三氟乙酸盐、晶型b及其制备方法、药物组合物和用途

Similar Documents

Publication Publication Date Title
JP2019505531A5 (https=)
JP2022133462A5 (https=)
JP2012501296A5 (https=)
JP2010513494A5 (https=)
JP2016512824A5 (https=)
JP2015524409A5 (https=)
HRP20210103T1 (hr) Postupak za proizvodnju spoja pirol0[3,2-d]pirimidina, kao i odgovarajućih intermedijera
JP2017505801A5 (https=)
JP2013538849A5 (https=)
JP2010536713A5 (https=)
JP2021504440A5 (https=)
JP2010511649A5 (https=)
WO2018032586A1 (zh) 一种3-(二氟甲基)-1-甲基-1h-吡唑-4-羧酸的合成方法及其中间体
JP6611942B2 (ja) オキサゾリジノン誘導体の中間体の製造方法{Preparation method of intermediate for oxazolidinone derivative}
US20080076932A1 (en) A process for the preparation of phenyltetrazole compounds
CN113336792A (zh) 一种环状膦酸酯化合物的制备方法
JP7252978B2 (ja) 2-(1-(tert-ブトキシカルボニル)ピペリジン-4-イル)安息香酸を調製するためのプロセス
JP2008533189A (ja) 1−置換1H−イミダゾ[4,5−c]キノリン−4−アミン化合物及びそれらのための中間体を製造するための方法
TW201041855A (en) New process for preparing
JP2016519669A5 (https=)
CN1117746C (zh) 制备取代的吡啶类化合物的方法及由该方法获得的吡啶类化合物
CN104080776B (zh) N-羟基-1-(1-烷基-1h-四唑-5-基)-1-苯基亚甲胺衍生物的制备方法
CN105037331B (zh) 瑞舒伐他汀中间体的制备方法
JPWO2014168139A1 (ja) 3,4,5−トリカフェオイルキナ酸の製造方法
JP2020023455A5 (https=)